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Abstract
Several different interventions improve depressed mood, including medication and environmental factors such as regular
physical exercise. The molecular pathways underlying these effects are still not fully understood. In this study, we sought to
identify shared mechanisms underlying antidepressant interventions. We studied three groups of mice: mice treated with a
widely used antidepressant drug – fluoxetine, mice engaged in voluntary exercise, and mice living in an enriched
environment. The hippocampi of treated mice were investigated at the molecular and cellular levels. Mice treated with
fluoxetine and mice who exercised daily showed, not only similar antidepressant behavior, but also similar changes in gene
expression and hippocampal neurons. These changes were not observed in mice with environmental enrichment. An
increase in neurogenesis and dendritic spine density was observed following four weeks of fluoxetine treatment and
voluntary exercise. A weighted gene co-expression network analysis revealed four different modules of co-expressed genes
that were correlated with the antidepressant effect. This network analysis enabled us to identify genes involved in the
molecular pathways underlying the effects of fluoxetine and exercise. The existence of both neuronal and gene expression
changes common to antidepressant drug and exercise suggests a shared mechanism underlying their effect. Further studies
of these findings may be used to uncover the molecular mechanisms of depression, and to identify new avenues of therapy.
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Introduction
A diverse set of interventions, in addition to drugs, is known to
have antidepressant action, including cognitive and electro-
convulsive therapies, sleep deprivation, and exercise [1,2].
Mechanistic understanding of what is common to environmental
and drug treatments may provide valuable clues about the mode
and site of action of antidepressants. Recent studies demonstrate
the importance of adult hippocampal neurogenesis for the action
of antidepressants [3,4]. Both exercise and enriched environment
have also been found to increase hippocampal neurogenesis [5]
and cause antidepressant-like behavioral change. Chronic exercise
reduces depressive-like behavior in rats [6,7] and mice [8], as
measured in standard models of depression such as the forced
swim test. Environmental enrichment has similar consequences [9]
and both produce notably similar effects on the brain in
stimulating cell proliferation and recruitment of new neurons into
the dentate gyrus of the hippocampus [5,10,11].
Currently no molecular pathway is known that is common to
these treatments. The finding that gene expression data show
structured correlation, together with the development of weighted
gene co-expression network analysis (WGCNA) [12,13], provide a
system-level approach for using gene expression to detect the
common mechanisms of different interventions. WGCNA orga-
nizes genes into modules that are co-regulated and therefore are
more likely to be functionally related and to participate in similar
cellular processes. WGCNA also alleviates the multiple testing
problem inherent in testing tens of thousands of transcripts, a
problem that otherwise substantially reduces the power of
standard differential expression analysis. Instead of testing the
changes in expression of each of thousands of genes, a small
number of gene co-expression modules are tested in the WGCNA
approach.
In this study we look for common molecular and neuronal
mechanisms for antidepressant action by studying the hippocampi
of mice exposed to three different interventions. We compared
changes in adult neurogenesis, neuronal plasticity, and gene
expression induced by exercise, environmental enrichment, and
fluoxetine, a specific serotonin reuptake inhibitor commonly
prescribed for major depression. We examined these phenotypes
in the hippocampus, because this brain structure has been
implicated in the pathophysiology and treatment of mood
disorders, and changes in adult neurogenesis in the hippocampus
are associated with exercise, environmental enrichment and
possibly also with the therapeutic effect of antidepressants.
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Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for Laboratory Animals Facilities
and Care as promulgated by the Council of Agriculture. Executive
Yuan, ROC. The protocol was approved by the Institutional
Animal Care and Use Committee of Chang Gung University
(Permit Number: CGU11-008). In this Protocol, all efforts were
made to minimize suffering.
Animals
Eight week old C57BL/6J male mice were individually housed
in standard cages (28635613 cm) with ad libitum access to food
and water for 28 days. Groups of mice were treated with one of the
following four protocols: (1) Exposure to an enriched environment:
cages were filled with toys, including tubes, ladders, balls and
shelters (but not a running wheel). Toys were changed every three
days. (2) Voluntary exercise: mice were housed with a free access
to a running wheel (Bio-Serv, US). Running distance on the wheel
was measured using standard bicycle odometers (Cateye Velo 8).
Previous studies showed that mice given access to running wheels
for 3–4 weeks showed robust antidepressant behavior [8] (3)
Chronic fluoxetine treatment: The mice were given fluoxetine
(80 mg/L) in their drinking water. Average intake was 16 mg/kg/
day of fluoxetine. Administration of this dose by oral administra-
tion for 28 days was shown before to produce a robust
antidepressant behavior in mice and increase in neurogenesis in
the hippocampus [3] (4) The control group: the control group of
mice was not exposed to any of the treatments. All groups were
housed at a controlled environment and kept on a 12 hour light/
dark cycle.
Immunohistochemistry
All sections for KI67 and DCX staining were cut to a thickness
of 40 mm on a sliding microtome. For KI67 staining, sections were
mounted on the superfrost slides (BDH, UK) and dried overnight.
Subsequently, slides were incubated in the 0.01 mol/L citric buffer
for 40 min at 90uC, 3% H2O2 for 10 min, rinsed in PBS, and
incubated overnight at room temperature in rabbit anti-KI67
antibody (1:4000, Vector Lab). Next day, a standard rabbit IgG
ABC kit (Vector Lab) procedure was used and the slides reacted
for 5–10 min with Sigma DAB tablet. Sections were then
counterstained with cresyl violet and cover-slipped with DPX.
KI67-labeled cells were counted bilaterally on every eighth section
through the entire rostrocaudal extent of the granule cell layer. For
DCX staining, free floating sections were incubated with goat anti-
DCX antibody (1:400, Santa Cruz Labs), then following the same
ABC kit procedure, reacted with Sigma DAB tablet. DCX-labeled
cells were counted bilaterally on every sixteenth section through
the entire rostrocaudal extent of the granule cell layer.
Fluorescent staining
For BrdU/NeuN double labeling, fluorescent staining was
performed on 40 mm floating sections. The sections were
incubated in 2M HCl for 30 min at 37uC, neutralised in boric
acid (Sigma) for 15 min (pH 8.5) and washed 3 times in PBS
before incubation with BrdU antibodies (Accurate Chemical and
Scientific; 1: 200) and NeuN (Chemicon; 1: 400). Following three
washes in PBS (5 min each), sections were incubated with the
fluorescent secondary antibody (1: 200, Alex Fluor 488 and Alex
Fluor 568, Invitrogen) for 2 h in 0.3% Triton/PBS with 2% of
goat serum. Images of sections were captured on a Zeiss LSM 510
META confocal microscope.
Golgi staining
Brains were harvested and stained using an FD rapid
Golgistain
TM Kit in accordance with the manufacturer’s instruc-
tion (FD Neuro Technologies) (n=3 for control group, n=4 for
exercise, enriched and fluoxetine groups). Brains were sectioned
coronally at a thickness of 80 mm using a microtome. Only spines
from apical CA1 dendrites in matched mid hippocampus sections
were used for analysis. Ten dendrites per brain were photo-
graphed using an Olympus BX-51 microscope equipped with a
1006 objective. Images freeware was used to measure dendrite
length and manually count spine number.
Expression analysis
The hippocampi of mice were isolated after 28 days and were
immediately frozen on dry ice. The hippocampi were homoge-
nized using 5-mm stainless steel beads (Qiagen) on a Tissue Lyser
(Retsch MM300 Mixer Mill) for 10 min at 25 Hz. Total RNA was
extracted using the RNeasy Lipid Tissue Kit (Qiagen) according to
the manufacturer’s instructions. RNA quantity and integrity were
assessed using a NanoDrop ND-1000 Spectrophotometer and an
Agilent 2100 Bioanalyser. All RNA samples had an RNA Integrity
Number (RIN).9.
One microgram of total RNA was used as starting material for
the expression analysis. The ribosomal RNA was removed using a
RiboMinus Mouse Transcriptome Isolation Kit (Invitrogen). RNA
samples were further processed according to the manufacturer’s
protocol using Affymetrix’s GeneChip Whole Transcript Sense
Target Labeling Assay. Fragmented and biotinylated cDNA were
added to the hybridization mixture and loaded on a Affymetrix
GeneChip Mouse Exon 1.0 ST array. After hybridization, the
array was washed and stained according to Affymetrix protocol
using the GeneChip Fluidics Station 450/250. The stained array
was scanned using an Affymetrix GeneChip Scanner 3000.
Quality control was carried out using Affymetrix Expression
Console Software Version 1.0. Signal estimates were derived from
the CEL files by quantile sketch normalization using the
IterPLIER for gene-level intensities using the Expression Console
software (Affymetrix). Only ‘‘core’’ level probe sets (probe sets
assigned to the highest confidence level) were used in the analysis.
Gene-level iterPLIER estimates are derived by combining
correlated probe sets, predicted to map into the same transcript
cluster (according to the meta-probe set list). The iterPLIER
algorithm iteratively discards probes that do not correlate well with
the overall gene-level signal and then recalculates the signal
estimate to derive a robust estimation of the gene expression value.
Genes were considered as expressed based on a ‘‘Detection Above
Background’’ (DABG) P,0.05 for 80% or more of the samples.
Figure 1. The enriched environment and running wheel used in
this study. (A) The photo shows cages with different toys, including
tubes, ladders, houses, balls. The toys in the enriched cages were
changed every three days. (B) The running wheel used with the exercise
group.
doi:10.1371/journal.pone.0035901.g001
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language and analyzed using analysis of variance (ANOVA). The
q-value (the proportion of false positives), for false discovery rate
control, was estimated using the ‘qvalue’ package for R.
Differential transcripts were identified as those with q-value#0.05.
The cell files from the study of Miller et al. that examine the effect
of fluoxetine on gene expression were retrieved from the Gene
Expression Omnibus (GEO), and reanalyzed using Affymetrix
Expression Console and normalized using the RMA algorithm.
The data and the experimental details can be found in the GEO
website (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE6476). In addition, we examined unpublished data that
examined the effect of chronic treatment of Clozapine and
Haloperidol on gene expression in the mouse brain (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6511).
Network analysis
A weighted gene coexpression network was constructed
according to previously described methodology. The network
was constructed using the 4000 most variable genes across all
samples. The network was constructed based on a pairwise
correlation matrix of the expression values. To approximate a
scale-free network topology, the data was transformed by a fixed
power (b=14). To identify gene modules, we followed the
standard WGCNA approach. Hierarchical clustering was per-
formed on the topological overlap dissimilarity matrix and the tree
was cut using a dynamic tree-cutting algorithm. Modules were
merged together if the modules eigengenes were highly correlated
(a correlation above 0.8). To test for association between
antidepressants and gene modules, the eigengene of each module
was tested for significant correlation to the trait. Testing for
overrepresentation of functional categories was carried out using
Database for Annotation, Visualization, and Integrated Discovery
(DAVID) tools, version 6.7 [14,15]. Categories analyzed included
GO categories, pathways database (KEGG Pathways), and
functional categories (SP PIR Keywords). The Benjamini
correction for multiple testing was applied with a threshold for
an adjusted P,0.05.
Behavior
For the open field test, mice were placed in a brightly lit, white,
and circular arena with a 60 cm diameter. This was divided into
an inner (40 cm in diameter) and an outer circular area. Mouse
movements were monitored for 5 min via an automated tracking
system (Videotrack. vNT4.0: Viewpoint). Marble burying was
tested by placing the mice individually into plastic cages
(20630 cm) containing a 5 cm layer of sawdust bedding and 12
glass marbles. Cages were placed on a Threshold system (Med
Figure 2. Cell survival and neurogenesis in the four different groups. BrdU (200 mg/kg) was injected into all mice before dividing them into
different groups. After 28 days, brain tissues (hippocampus) were stained for BrdU and NeuN (A–C). The exercise and fluoxetine groups, but not the
enriched environment group, showed higher number of BrdU and NeuN positive cells in the dentate gyrus (D) compared to the control group. Values
are means 6 SEM. **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0035901.g002
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behavior for 30 min.
For novelty suppressed feeding, mice were food deprived for
24 h and then placed in a novel rodent cage (30650 cm) that
contained mouse predator odor (rat feces and fur) for 6 min. Four
regular food pellets were placed in the corner of the cage. The
total time that the mice spent eating was recorded. After the test,
mice were placed back in their home cage with food pellets. The
consumption of food pellets (g) were measured within the first
30 min. For novelty induced hypophagia, mice were given the
sweetened milk in their home cage, twice a day for three days. On
the fourth day, the latency and time spent drinking within 6 min in
their home cage under dim lighting conditions was measured. On
the fifth day, the latency to time spent on the drinking in their
home cage after relocation to a novel, brightly lit room was scored.
Results
Fluoxetine and voluntary exercise increase neurogenesis
and spine density
C57BL/6J mice (8 weeks old, n=10) were divided into four
groups. All the mice were given one injection of BrdU to label the
dividing cells (ip, 200 mg/kg). The first group was exposed to an
environment enriched with toys, including different shaped tubes,
ladders, balls and housing (Figure 1A), which were changed every
three days. A second group of mice was housed with free access to
a running wheel (Figure 1B). The average running distance, as
measured by standard bicycle odometers, was 12 km per day. The
third group was given fluoxetine in their drinking water (80 mg/
L). A fourth control group of ten mice was not exposed to any of
the above treatments.
After 28 days, the mice were analyzed for the levels of adult
neurogenesis (n=6) and neuronal spine density (n=4). A higher
neuronal survival level was observed in mice belonging to the
exercise and fluoxetine groups relative to controls, as indicated by
the number of BrdU+/NeuN+ labeled cells (Figure 2 A–D)
(exercise vs. control: P,0.001, t=5.15; fluoxetine vs. control:
P,0.01, t=4.44). Approximately 80% of the BrdU positive cells
were also positive for the neuronal marker, NeuN; however there
were no differences in the percentage of BrdU/NeuN co-labeling
between the four groups (P=0.76). Unlike the BrdU labeling, a
significant increase in KI67, which is a marker for proliferation,
was observed only for animals treated with fluoxetine (P,0.01,
t=4.42). To estimate the level of ongoing neurogenesis, we used a
marker for immature neurons – doublecortin (DCX). Both the
exercise and fluoxetine groups showed an increase in neurogenesis
as indicated by the DCX staining (Figure 3 A and B) (exercise vs.
control: P,0.001, t=4.7; fluoxetine vs. control: P,0.001, t=7.9).
We also detected a higher level of neuronal spine density, by
sampling from the CA1 region, in animals from both exercise and
fluoxetine groups (Figure 3 C and D) (exercise vs. control: P,0.05;
fluoxetine vs. control: P,0.01, t=3.4). Overall, these results show
that both voluntary exercise and fluoxetine treatment, but not
enriched environment, increase adult neurogenesis and dendritic
spine density after 28 days of intervention.
Similar changes in gene expression with fluoxetine and
exercise interventions
We examined gene expression in the hippocampus of seven
mice from each group, after 28 days of treatment. We analyzed
23,238 genes, out of which 11,318 genes (48.7%) were found to be
expressed. Using analysis of variance (ANOVA), we identified 87
Figure 3. DCX staining and dendritic spine density in the hippocampus. (A and B) The exercise and fluoxetine groups showed more
immature neurons in the dentate gyrus compared to controls. (C and D) Golgi staining images reveal higher level of dendritic spine density in the
hippocampus (CA1 region) in the exercise and fluoxetine groups. Values are means 6 SEM. *P,0.05, ***P,0.001. Scale bar show 200 mm (A) and
10 mm (B).
doi:10.1371/journal.pone.0035901.g003
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Gene ontology enrichment analyses and functional annotation
clustering identified an enrichment of functional groups including:
secreted [SP PIR Keywords] (q-value=2.0610
27), extracellular
region [GO:0005576] (q-value=2.1610
27), glycoprotein [SP PIR
Keywords] (q-value=1.5610
26), extracellular region
[GO:0005576] (q-value=2.1610
27) and ECM-receptor interac-
tion [KEGG PATHWAY] (q-value=5.4610
23).
Similar to the results obtained for neurogenesis, the gene
expression data pointed to a closer relationship between voluntary
exercise and the drug treatment than between enriched environ-
ment and either of the other interventions (Figure 4 A and B). The
correlation between the expression ratios (treatment vs. control) of
the two treatment groups, fluoxetine and voluntary exercise, across
all genes was 0.49, relative to a correlation of 0.15 between the
enriched environment and fluoxetine.
Out of the 87 genes showing significant differential expression
between the groups, four genes had a P,0.05 in the enriched
environment group, 37 had a P,0.05 in the exercise group, and
84 had a P,0.05 in the fluoxetine group, in comparisons with the
control group. Surprisingly, out of the 87 genes, the expression of
34 genes was significantly (P,0.05) altered in both the fluoxetine
Figure 4. Hippocampal gene expression profiles in response to different antidepressant treatments. (A) Changes in expression
following exercise compared with the changes in the fluoxetine treated group. Each point is the average expression level of the treated group
divided by the average expression level in the control group for one of the 87 genes showing significant differential expression. The Y and X axes are
on a log scale, base 2. The line is the best fit linear regression. (B) Changes in expression in an enriched environment as a function of the changes in
the fluoxetine treated group. (C) Changes in expression for 36 genes (out of 87) with the highest fold change following chronic fluoxetine treatment
compared to controls. (D) Comparison of the effect of fluoxetine on gene expression in the current study with the results obtained by Miller et al.
(2008) [17].
doi:10.1371/journal.pone.0035901.g004
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same direction (upregulated or downregulated) in both groups.
Moreover, even the genes that were not significant (P.0.05) in the
exercise group showed the same trend as was observed in the
fluoxetine group. Of the 84 genes showing significant differential
expression in the fluoxetine group (Figure 4C), 60 were
upregulated, and 24 were downregulated following fluoxetine
treatment. Out of the 60 fluoxetine upregulated genes, 55 also
showed higher expression in the exercise group relative to controls,
and out of the 24 fluoxetine downregulated genes, 13 were also
lower in the voluntary exercise group (P=0.00027) (Table S1).
Among the genes upregulated in both fluoxetine and voluntary
exercise groups was Bdnf, a gene extensively studied as being a
possible mediator of the effect of antidepressant treatments [16].
We further measured the expression of three differentially
expressed genes (Bdnf, Nptx2 and Plekha2) by real-time PCR
(Figure 5). Similar to the array results (Figure 5A) the three genes
were upregulated relative to control (Figure 5B), with highest
expression in the fluoxetine group.
In order to further exclude the possibility of an artefactual
explanation for our results we searched for expression data carried
out by others on mice treated with any of the antidepressant
treatments, fluoxetine or voluntary exercise. We found one study
in the Gene Expression Omnibus (GEO), which profiled
hippocampal gene expression from DBA/2J males chronically
treated with fluoxetine [17]. Of the 87 genes regulated by
antidepressant treatment in our study, there were data for 75 on
the arrays of Miller et al. [17]. Of the 56 hippocampal fluoxetine
upregulated genes in our study, 55 had a ratio above 1 in the data
of Miller et al. (mean ratio=1.45) and out of the 19 down
regulated genes, 15 had a ratio below 1 (mean ratio=0.83) in the
previous study (P=1.28610
211). The correlation between the
expression ratios in the two studies (for the 75 significant genes)
was 0.57, with corresponding P=1.27610
27 (Figure 4D). This
very strong correlation confirms that the expression results we
obtained are unlikely to be due to factors specific to our
experiment.
We also compared our results with data from a study that
examined gene expression in mice treated with antipsychotic drugs
(unpublished data, GEO: GSE6511). We analyzed the expression
from brains of mice treated with Clozapine, Haloperidol and
Control (n=3 in each group) for four weeks. Of the 87 genes
differentially expressed in our data, 48 were available in this
dataset, and only 1 of them (Rgs8) was among the 100 most
significantly differentially expressed genes following chronic
treatment with either Clozapine or Haloperidol. We conclude
that the genes influenced by antipsychotic drugs do not overlap
with the genes influenced by fluoxetine or exercise.
A gene co-expression network analysis identifies
modules associated with antidepressant interventions
To study the relation between antidepressant action and gene
expression, we applied a weighted-gene co-expression network
analysis (WGCNA) to identify modules of co-expressed genes. A
network was constructed using a pairwise correlation matrix of the
expression of the 4,000 most variable genes across all samples. We
performed hierarchical clustering on the topological overlap
dissimilarity matrix and found 11 modules after merging those
that were highly correlated. In order to discover modules
associated with the antidepressant treatments, we tested the
correlation between each module’s eigengenes (defined as the first
principal components) and both interventions (fluoxetine and
exercise versus control). Four modules showed significant (P,0.05)
association with antidepressant treatments (Table 1, and
Figure 6A). For each gene within the modules we also calculated
the gene significance – the correlation between the expression
profile across samples of each gene and the antidepressant
treatment. In addition, for each module, and for each gene, we
calculated the module membership, which is the correlation
between the gene expression and the module eigengene (summa-
rized in Table 1). The correlation between the gene significance
and the module membership score was significant (P,0.05) in the
four modules, illustrating that genes significantly associated with
antidepressant treatments are often also the most important
elements in this modules.
Out of the four modules, two were positively and two negatively
correlated with fluoxetine and exercise (Table 1). Gene enrich-
ment and functional annotation analyses revealed that the
modules are enriched for specific processes (Figure 6B). The
module showing the most consistent effect (Light green) in both
fluoxetine and exercise was upregulated compared to control, and
was enriched for genes belonging to the proteasome. Another
module that was modestly and negatively correlated with
fluoxetine and exercise when tested together, was the one most
significantly correlated to fluoxetine when tested alone (correla-
tion=20.61, P=5 610
24). This module is downregulated by
antidepressants and is enriched for genes involved in neuronal
differentiation and maturation (Figure 6B).
Figure 5. Validation by real-time PCR of three genes that show
differential expression in the microarray analysis. The expression
of Nptx2, Bdnf and Plekha2 is shown for the fluoxetine and exercise
groups relative to control. (A) Relative expression based on (A)
expression arrays and (B) real-time PCR. Values are means 6 SEM.
*P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0035901.g005
Shared Mechanism of Exercise and Fluoxetine
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35901Table 1. Modules of co-expressed genes associated with antidepressant interventions.
Module Yellow Light green Dark grey Royal blue
No. of genes: 310 102 47 87
Correlation
1: 0.6 0.56 20.47 20.37
Significance: 8610
24 0.002 0.01 0.05
10 most significant genes within each module
1 Dpy19l3 Snx25 Leng8 Vwa3a
2 Plekha2 Akirin2 Mfsd5 Igfbp5
3 Kcnk1 Uxs1 R3hdm1 Mkl2
4 Darc Psmb6 Tnrc6b Hap1
5 Slc7a14 Tmem223 Psmd2 Pnck
6 Grasp Park2 Abcb1a Smarca2
7 Dbc1 Nsg1 Gnb2l1 Ntng1
8 Bdnf AB041803 N28178 Sorbs1
9 Rgs8 Slc38a2 Pnet-ps Rasgrf2
10 Kif17 Dctn3 Nktr Tub
1correlation between module eigengene and antidepressant interventions (exercise and fluoxetine).
In bold are the gene with the highest module membership score.
doi:10.1371/journal.pone.0035901.t001
Figure 6. Modules significantly correlated with exercise and fluoxetine. (A) (Upper) Barplots of the values of the module eigengene (i.e., the
first principal component) derived from singular value decomposition are displayed for the four modules significantly correlated with exercise and
fluoxetine (yellow, light green, dark grey and royal blue). (Lower) Heat maps depicting expression levels for each module (Red, increased expression;
green, decreased expression relative to the mean), for all genes (rows) and group of mice (columns): C, control; E, enriched environment; F, fluoxetine;
R, exercise (running wheel). (B) Gene enrichment and functional annotation analyses of genes in the different modules using DAVID bioinformatics
[14,15]. No significant enrichment was found in the Dark grey module.
doi:10.1371/journal.pone.0035901.g006
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fluoxetine treatment
We tested whether voluntary exercise had the expected
antidepressant effects by comparing exercising animals to controls
in behaviors that were found to be modulated in response to
fluoxetine: novelty suppressed feeding [18], marble burying and
digging activity in a new environment [19] [20], and novelty
induced hypophagia [21]. Mice given free access to a running
wheel did not show significant differences of total activity in an
open field arena (Figure 7A). However, they did exhibit
significantly less burying and digging activities in a new cage
compared to controls (t=2.69, df=14, P,0.05) (Figure 7B). In the
novelty suppressed feeding test, the exercise group showed a
significant increase in the time spent in eating food in an aversive
environment after overnight food deprivation (t=2.72, df=14,
P,0.05) (Figure 7C). However, there was no difference in the
amount of food consumption in the home cage within 30 minutes
immediately after the novelty suppressed feeding test (P=0.18,
t=1.38) (Figure 7D). Similarly, in the novelty induced hypophagia
test, the exercise group showed a significant increase in the time
spent drinking in a bright cage (P,0.01, t=4.1) (Figure 7E), with
no differences in a dark cage (P=0.7, t=0.38) (Figure 7F).These
results confirm that voluntary exercise affects behavior in way
which is comparable to chronic fluoxetine treatment.
Discussion
Using a neurogenomics approach to uncover the changes
following antidepressant treatments at the molecular, neuronal
and behavior levels, we found significant alterations in multiple
levels that are common to both exercise and fluoxetine treatments,
but are not shared with environmental enrichment. Our results
suggest that there is a shared mechanism underlying the
antidepressant effect of fluoxetine and exercise. We have identified
similar changes in neurogenesis and structural plasticity in the
hippocampus of mice following chronic fluoxetine treatment and
voluntary exercise. A co-expression network analysis revealed
changes of specific groups of genes in the mouse hippocampus in
response to antidepressant treatments.
Gene expression is subject to a large number of confounds,
unrelated to the intervention under examination, but we believe
our findings are robust for a number of reasons. Most strikingly, an
independent analysis identified a highly significant overlap in the
differentially expressed set of genes: the correlation between the
expression ratios in the two studies was 0.57, with a corresponding
of P=1.27610
27. Second, the variances in our gene expression
data were low, due to the fact that we used an exon array which
has approximately 40 probes per gene, providing a very accurate
measurement of gene expression. Third, among the genes
upregulated in both the fluoxetine and exercise groups was Bdnf,
a gene extensively studied as being a possible mediator of the effect
of antidepressant treatments [16].
Several consistent changes were observed in response to exercise
and fluoxetine treatments, which may reveal a core mechanism of
antidepressant action. Increase in neurogenesis was observed in
both treatments as indicated by staining of immature neurons with
DCX. Neuronal survival rates, as indicated by BrdU+/NeuN+
double labeling, were also higher in the exercise and fluoxetine
groups. In addition, in both groups there was an increase in spine
density. These changes at the cellular levels can be also related to
the corresponding changes in gene expression. The most
consistent finding at the network level was the upregulation of
Figure 7. Antidepressant-like behavior in mice engaged in voluntary exercise for 28 days (n=8). A series of antidepressant-like
behavioral tests were conducted. (A) There was no significant difference in the activity in the open field test. (B) Exercise group showed lower levels
of digging activity in a new cage with a 5 cm layer of sawdust bedding. (C) In the novelty suppressed feeding test, the exercise group increased the
time spent in eating in a rat odor cage compared to controls. No significant differences between the groups in food consumption at the home cage.
(D) In the novelty induced hypophagia test, the exercise group spent more time drinking sweet milk under bright lighting cage condition, but no
significant differences were observed under dim lighting cage conditions. Values are means 6 SEM. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0035901.g007
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function of the proteasome. The upregulation of proteasome genes
might be connected to the increase in dendritic spine density, since
this process has very high and dynamic degradative demands [22].
Our analyses indicate that genes showing altered expression
following antidepressant treatment cluster into specific co-
expression networks. These modules allowed us to identify key
genes in the pathways affected by antidepressant treatment based
on their membership in modules with known biological roles, and
to relate the modules to neuronal changes. From these results, we
conclude that at least part of the antidepressant effect of exercise
and fluoxetine is shared, in particular changes in neurogenesis and
dendritic spine density, and that these processes may be further
studied to identify new targets for the treatment of depression.
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